Related Experiment Videos
Prognostic factors in polyarteritis. Summary This summary is machine-generated. Polyarteritis prognosis is critical in the first three months, with older age and specific organ involvement indicating a poorer outcome. Cutaneous vasculitis suggests a more favorable course for patients with polyarteritis.
You might also read
Related Articles Articles linked to this work by shared authors, journal, and citation graph.
All12 Same author6 Same journal6
Area of Science:
Rheumatology Internal Medicine Pathology Background:
Polyarteritis is a serious systemic vasculitis with variable clinical presentations. Identifying prognostic factors and optimal treatment is crucial for patient outcomes. Purpose of the Study:
To review the clinical course of 40 patients with polyarteritis. To determine prognostic factors and evaluate treatment responses. Main Methods:
Retrospective review of 40 patients with polyarteritis. Analysis of clinical data, including organ involvement, symptoms, and diagnostic procedures. Evaluation of treatment efficacy, particularly corticosteroid dosage.
Related Experiment Videos
The initial three months were critical for survival, with a five-year survivorship of 57%.
Older age, skeletal muscle involvement, and peripheral neuropathy were associated with poorer outcomes.
Cutaneous vasculitis indicated a more benign course; myocardial, CNS, or hypertension were not invariably poor prognostic factors.
Muscle biopsies and renal angiograms proved valuable diagnostic tools.
Distinguishing between specific types of vasculitis (polyarteritis nodosa, hypersensitivity angiitis, allergic granulomatosis) was challenging.
Australia antigenemia was present in 6% of patients.
High-dose corticosteroids did not demonstrate superiority over low-dose in suppressing active disease. Conclusions:
Prognosis in polyarteritis is influenced by age of onset and specific organ involvement. Early diagnosis and monitoring are essential, with the first three months being pivotal. Diagnostic modalities like muscle biopsy and renal angiography are valuable. Current data do not support a significant benefit of high-dose corticosteroids over low-dose for disease suppression.